Cyclone toll hits 84 as Bangladesh and India start mopping up

An aerial view shows volunteers and residents working to fix a damaged dam following the landfall of cyclone Amphan in Burigoalini on May 21, 2020. (AFP)
Short Url
Updated 22 May 2020

Cyclone toll hits 84 as Bangladesh and India start mopping up

  • The UN office in Bangladesh estimates 10 million people were affected, and some 500,000 people may have lost their homes

SATKHIRA: India and Bangladesh began a massive clean-up Thursday after the fiercest cyclone since 1999 killed at least 84 people, leaving a trail of destruction in its wake.
Cyclone Amphan flattened houses, uprooted trees, blew off roofs and toppled electricity pylons, while a storm surge inundated coastal villages and wrecked shrimp farms vital to the local economy.
The United Nations office in Bangladesh estimates 10 million people were affected, and some 500,000 people may have lost their homes.
But the death toll was far lower than the many thousands killed in previous cyclones — a result of improved weather forecasting and better response plans.
The disaster has raised fears, however, that overcrowding in storm shelters will exacerbate the spread of coronavirus.
India’s West Bengal reported 72 deaths — including 14 in the capital Kolkata — with state premier Mamata Banerjee saying: “I haven’t seen a disaster of this magnitude.”
In Bangladesh, the official death toll was 12.

Improved weather forecasting meant Bangladesh was able to move some 2.4 million people into shelters or out of the storm’s direct path, while India evacuated some 650,000.
At least 10 million people were still without power on Thursday afternoon in the worst-hit districts of Bangladesh, said Moin Uddin, the head of the rural electricity board.
“Huge number of electricity poles fell down after it was lashed by the cyclone, or they were hit by huge number of fallen trees. Transformers, conductors and meters were also destroyed,” he told AFP.
Residents of Kolkata woke to flooded streets, with the city’s signature yellow taxis up to their bonnets in water in one neighborhood.
“The impact of Amphan is worse than coronavirus,” premier Banerjee said. “Thousands of mud huts have been levelled, trees uprooted, roads washed away and crops destroyed.”
Other officials said they were waiting for damage reports from the Sundarbans, the vast mangrove area that is home to endangered Bengal tigers and which bore the brunt of the storm.
“We are particularly concerned over some wild animals. They can be washed away during a storm surge in high tide,” forest chief Moyeen Uddin Khan told AFP.
The cyclone weakened as it moved north through Bangladesh but still unleashed heavy rain and fierce winds in Cox’s Bazar, the district which houses about one million Rohingya refugees from Myanmar.
The UN said that the effect in the vast camps of flimsy shacks appeared to be “fairly minimal.”
The area most affected by Amphan, the first “super cyclone” to form over the Bay of Bengal since 1999, was the Satkhira district of south-west Bangladesh.
There a storm surge — a wall of ocean water that is often one of the main killers in major weather systems — roared inland and destroyed embankments protecting villages and shrimp farms.
In the village of Purba Durgabati, hundreds of locals worked through the night to mend a breach in a levee, but to no avail. Some 600 homes and thousands of shrimp farms were hit.
“My home has gone under water. My shrimp farm is gone. I don’t know how I am going to survive,” Omar Faruq, 28, told AFP.
“The coronavirus has already taken a toll on people. Now the cyclone has made them paupers,” said local councillor Bhabotosh Kumar Mondal.
The last super cyclone in 1999 left nearly 10,000 dead in India’s Odisha state, eight years after a typhoon, tornadoes and flooding killed 139,000 in Bangladesh.
This time, as during a cyclone in Odisha last year, the human cost was greatly lessened thanks to the evacuations, said Enamur Rahman, Bangladesh’s junior minister for disaster management.
“Only several people died. The majority of them ventured out to collect fallen mangoes during the storm,” Rahman told AFP.
Natural disaster expert Nayeem Wahra, at the Disaster Forum think-tank, said the storm also lost some of its potency over the Bay of Bengal before it made landfall .
“The storm surge was not powerful or high enough to cause extensive damage to lives or properties,” Wahra told AFP.
“Bangladesh was largely spared.”
Packing people into shelters, however, raised the risk of coronavirus spreading, with cases still surging in both India and Bangladesh.
Authorities said they extended shelters to reduce crowding, while also insisting everyone wore face masks.
Many, however, chose to stay at home and face the storm rather than risk being infected.
“We fear the cyclone but we also fear the coronavirus,” said Sulata Munda, a villager in Bangladesh who refused to go to a shelter.


Indonesia begins human trials of anti-virus vaccine

Updated 50 min 3 sec ago

Indonesia begins human trials of anti-virus vaccine

  • The third phase of the clinical trials of the vaccine — which is manufactured by China’s Sinovac Biotech in collaboration with its Indonesian pharma counterpart, Bio Farma — began on Tuesday
  • The third phase is a must before the vaccine, known as CoronaVac, goes into the production stage and is a prerequisite for all pharmaceutical products, including medicines and vaccines

JAKARTA: Indonesia is stepping up efforts to find a COVID-19 vaccine by launching human trials of a potentially effective drug amid criticism of its lacklustre handling of the pandemic and concerns about its plummeting economy.

The third phase of the clinical trials of the vaccine — which is manufactured by China’s Sinovac Biotech in collaboration with its Indonesian pharma counterpart, Bio Farma — began on Tuesday and is being conducted by the Padjadjaran University School of Medicine at six locations in Bandung, West Java province, where the university and the state-owned pharma company are based.

“The first day of the trial went well, with 20 volunteers in each of the six locations injected with the potential vaccine. We have no complaints so far, and we are preparing the second injection batch on Aug 14,” Iwan Setiawan, a spokesman for Bio Farma, told Arab News on Wednesday.

He added that the six-month trial would require the participation of 1,620 volunteers who were “in good health and had not tested positive” for the disease.

Ridwan Kamil, governor of West Java, Indonesia’s most populated province, is among the volunteers who have signed up for the trial.

The third phase is a must before the vaccine, known as CoronaVac, goes into the production stage and is a prerequisite for all pharmaceutical products, including medicines and vaccines.

“The potential vaccine had gone through three trials; the pre-clinical, the clinical trial first phase and the second phase in China,” Bio Farma CEO Honesti Basyir said in a statement.

According to Basyir, Sinovac is one of the few institutions that have progressed to the third phase of the clinical trial from among hundreds of research institutions around the world that are developing the COVID-19 vaccine.

According to Oxford Business Group’s COVID-10 Economic Impact Assessment, there are more than 150 different vaccines that international researchers are working on. However, only 26 have reached the human trial stage so far.

Once the trials are concluded, Bio Farma will register the vaccine with the Food and Drug Supervisory Agency so that it can begin mass-production of the drug.

“We have prepared a production facility for the COVID-19 vaccine with a maximum capacity of 100 million dosages, and by the end of December this year we will have an increased production capacity to produce an additional 150 million dosages,” Basyir said.

President Joko Widodo oversaw the first injections to the batch of volunteers in one of the six locations and also toured Bio Farma’s production facility. 

“We hope this clinical trial would conclude in six months and so we can start producing the vaccine in January and vaccinate our people soon,” Widodo said.

State-Owned Enterprise Minister Erick Thohir, who is also the head of the COVID-19 mitigation and national economic recovery committee, said that Bio Farma was a well-established vaccine producer whose products were halal-compliant and used in 150 countries, including in the Middle East.

The collaboration with Sinovac is one of three vaccine-development projects that Indonesia is engaging in with foreign parties as it grapples with a surge in infections. At the same time, social restrictions and economic activities were eased. The other two projects are with South Korea’s Genexine and Norway’s Coalition for Epidemic, Preparedness and Innovation.

As of Wednesday, Indonesia had reported 130,718 infections with 1,942 new cases, 85,798 recoveries and 5,903 deaths, although experts suggest that the numbers could be higher due to the country’s low testing capacity.

Cases also surged in the capital Jakarta with workplaces emerging as the new infection clusters after thousands of employees returned to work recently.